NCT03319160View on ClinicalTrials.gov

LifeVest Safety and Efficacy in Real Life Settings in France

CompletedOBSERVATIONAL
Enrollment

1,164

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

March 30, 2019

Conditions
Sudden Cardiac DeathLeft Ventricular DysfunctionCardiac EventCardiac Arrythmias
Interventions
DEVICE

Wearable Cardioverter Defibrillator

A non-invasive wearable cardioverter defibrillator detects and treats VT/VF without the need for bystander intervention

Trial Locations (2)

Unknown

Hôpital Européen Georges Pompidou, Paris

Clinique PASTEUR, Toulouse

All Listed Sponsors
lead

Zoll Medical Corporation

INDUSTRY

NCT03319160 - LifeVest Safety and Efficacy in Real Life Settings in France | Biotech Hunter | Biotech Hunter